MACK
Merrimack Pharmaceuticals, Inc.
MACK
MACK
Delisted
MACK was delisted on the 17th of May, 2024.
63 hedge funds and large institutions have $104M invested in Merrimack Pharmaceuticals, Inc. in 2023 Q3 according to their latest regulatory filings, with 7 funds opening new positions, 17 increasing their positions, 16 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
2% more funds holding
Funds holding: 62 → 63 (+1)
6% more repeat investments, than reductions
Existing positions increased: 17 | Existing positions reduced: 16
Holders
63
Holding in Top 10
4
Calls
$3.74M
Puts
$1.66M
Top Buyers
| 1 | +$2.73M | |
| 2 | +$2.32M | |
| 3 | +$1.69M | |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$1.02M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$537K |
Top Sellers
| 1 | -$1.37M | |
| 2 | -$1.07M | |
| 3 | -$571K | |
| 4 |
Connor, Clark & Lunn Investment Management (CC&L)
Vancouver,
British Columbia, Canada
|
-$177K |
| 5 |
Dimensional Fund Advisors
Austin,
Texas
|
-$138K |